MUPIROCIN - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for mupirocin and what is the scope of freedom to operate?

Mupirocin is the generic ingredient in three branded drugs marketed by Glaxosmithkline, Padagis Us, Fougera Pharms, Glenmark Pharms, Padagis Israel, Taro, Teva, Alembic, Amneal, Encube, and Glenmark Pharms Inc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are sixteen drug master file entries for mupirocin. Twenty-one suppliers are listed for this compound.

Summary for MUPIROCIN

US Patents:	0
Tradenames:	3
Applicants:	11
NDAs:	15
Drug Master File Entries:	16
Finished Product Suppliers / Packagers:	21
Raw Ingredient (Bulk) Api Vendors:	87
Clinical Trials:	82
Patent Applications:	6,502
Drug Prices:	Drug price trends for MUPIROCIN
Drug Sales Revenues:	Drug sales revenues for MUPIROCIN
What excipients (inactive ingredients) are in MUPIROCIN?	MUPIROCIN excipients list
DailyMed Link:	MUPIROCIN at DailyMed

See drug prices for MUPIROCIN

See drug sales revenues for MUPIROCIN

Recent Clinical Trials for MUPIROCIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Victoriano Luna Medical Center	Early Phase 1
Jiangxi Provincial Cancer Hospital	Phase 3
Future University in Egypt	Phase 2/Phase 3

See all MUPIROCIN clinical trials

Pharmacology for MUPIROCIN

Drug Class	RNA Synthetase Inhibitor Antibacterial
Mechanism of Action	RNA Synthetase Inhibitors

Medical Subject Heading (MeSH) Categories for MUPIROCIN

Anti-Bacterial Agents
Protein Synthesis Inhibitors

Anatomical Therapeutic Chemical (ATC) Classes for MUPIROCIN

D06AX	Other antibiotics for topical use
D06A	ANTIBIOTICS FOR TOPICAL USE
D06	ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D	Dermatologicals

R01AX	Other nasal preparations
R01A	DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE
R01	NASAL PREPARATIONS
R	Respiratory system

US Patents and Regulatory Information for MUPIROCIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Encube	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	213076-001	Aug 31, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Glenmark Pharms	MUPIROCIN	mupirocin	OINTMENT;TOPICAL	090480-001	Jun 8, 2011	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Padagis Israel	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	212465-001	Aug 3, 2022		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alembic	MUPIROCIN	mupirocin calcium	CREAM;TOPICAL	213053-001	Nov 16, 2021	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for MUPIROCIN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Padagis Us	CENTANY	mupirocin	OINTMENT;TOPICAL	050788-001	Dec 4, 2002	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.